AIkido Pharma (AIKI) Competitors $5.26 -0.37 (-6.57%) As of 05/20/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock AIKI vs. NOTV, LUNA, ONMD, BIAF, ISPC, DKDCA, IQV, INCY, ICLR, and MEDPShould you be buying AIkido Pharma stock or one of its competitors? The main competitors of AIkido Pharma include Inotiv (NOTV), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), ICON Public (ICLR), and Medpace (MEDP). These companies are all part of the "commercial physical research" industry. AIkido Pharma vs. Inotiv Luna Innovations OneMedNet bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Medpace AIkido Pharma (NASDAQ:AIKI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, community ranking, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings. Is AIKI or NOTV more profitable? AIkido Pharma has a net margin of 0.00% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat AIkido Pharma's return on equity.Company Net Margins Return on Equity Return on Assets AIkido PharmaN/A -18.21% -16.94% Inotiv -25.40%-15.41%-3.58% Does the MarketBeat Community believe in AIKI or NOTV? AIkido Pharma received 81 more outperform votes than Inotiv when rated by MarketBeat users. Likewise, 63.92% of users gave AIkido Pharma an outperform vote while only 50.00% of users gave Inotiv an outperform vote. CompanyUnderperformOutperformAIkido PharmaOutperform Votes10163.92% Underperform Votes5736.08% InotivOutperform Votes2050.00% Underperform Votes2050.00% Which has higher valuation and earnings, AIKI or NOTV? AIkido Pharma has higher earnings, but lower revenue than Inotiv. AIkido Pharma is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAIkido Pharma$10K2,885.11-$7.17M-$3.88-1.36Inotiv$480.40M0.15-$108.44M-$3.19-0.66 Does the media favor AIKI or NOTV? In the previous week, Inotiv's average media sentiment score of 1.83 beat AIkido Pharma's score of 0.00 indicating that Inotiv is being referred to more favorably in the news media. Company Overall Sentiment AIkido Pharma Neutral Inotiv Very Positive Which has more risk & volatility, AIKI or NOTV? AIkido Pharma has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Inotiv has a beta of 4.03, indicating that its share price is 303% more volatile than the S&P 500. Do analysts prefer AIKI or NOTV? Inotiv has a consensus price target of $5.00, indicating a potential upside of 135.96%. Given Inotiv's stronger consensus rating and higher possible upside, analysts plainly believe Inotiv is more favorable than AIkido Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AIkido Pharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in AIKI or NOTV? 10.9% of AIkido Pharma shares are held by institutional investors. Comparatively, 18.2% of Inotiv shares are held by institutional investors. 8.6% of AIkido Pharma shares are held by insiders. Comparatively, 7.8% of Inotiv shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryInotiv beats AIkido Pharma on 11 of the 17 factors compared between the two stocks. Get AIkido Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AIKI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIKI vs. The Competition Export to ExcelMetricAIkido PharmaCommercial physical research IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.85M$2.98B$5.42B$8.48BDividend YieldN/A2.27%5.22%4.11%P/E Ratio-1.36105.7626.7820.05Price / Sales2,885.11164.75395.49116.44Price / CashN/A34.5738.2534.62Price / Book0.272.426.874.61Net Income-$7.17M$113.28M$3.22B$248.19M7 Day Performance-8.04%1.77%5.69%2.56%1 Month Performance31.83%2.52%12.66%16.18%1 Year Performance145.81%-8.44%18.01%8.16% AIkido Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIKIAIkido PharmaN/A$5.26-6.6%N/A+163.8%$28.85M$10,000.00-1.364High Trading VolumeNOTVInotiv2.3518 of 5 stars$2.11-3.7%$6.25+196.2%+19.6%$71.15M$475.11M-0.462,100Gap UpLUNALuna InnovationsN/A$0.39-2.5%N/A-82.4%$13.24M$116.61M0.00390News CoverageAnalyst ForecastONMDOneMedNet0.9298 of 5 stars$0.42+8.1%N/A-13.5%$12.77M$643,000.00-1.152Earnings ReportBIAFbioAffinity Technologies1.9856 of 5 stars$0.21+2.7%$6.00+2,821.1%-86.9%$3.75M$9.36M-0.2510Earnings ReportGap UpISPCiSpecimen0.2955 of 5 stars$1.19+1.7%N/A+373.0%$2.97M$9.29M-0.0660Earnings ReportDKDCAData Knights AcquisitionN/A$0.41-6.9%N/A-7.1%$2.12MN/A-2.162High Trading VolumeIQVIQVIA4.9433 of 5 stars$152.46-2.4%$231.71+52.0%-37.0%$26.38B$15.50B20.3386,000Positive NewsAnalyst ForecastINCYIncyte4.8948 of 5 stars$60.68-0.3%$73.53+21.2%+14.2%$11.75B$4.41B224.752,320Positive NewsICLRICON Public4.4683 of 5 stars$137.71-1.8%$215.33+56.4%-58.6%$11.12B$8.19B14.4541,100MEDPMedpace4.7814 of 5 stars$307.58-2.0%$349.30+13.6%-22.8%$8.84B$2.16B24.355,200Positive News Related Companies and Tools Related Companies Inotiv Alternatives Luna Innovations Alternatives OneMedNet Alternatives bioAffinity Technologies Alternatives iSpecimen Alternatives Data Knights Acquisition Alternatives IQVIA Alternatives Incyte Alternatives ICON Public Alternatives Medpace Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIKI) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIkido Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIkido Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AIKI Stock Free AIKI Stock Alerts